Growth Metrics

Quest Diagnostics (DGX) Change in Receivables (2016 - 2026)

Quest Diagnostics' Change in Receivables history spans 18 years, with the latest figure at $180.0 million for Q1 2026.

  • On a quarterly basis, Change in Receivables rose 78.22% to $180.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $185.0 million, a 218.97% increase, with the full-year FY2025 number at $106.0 million, up 49.3% from a year prior.
  • Change in Receivables hit $180.0 million in Q1 2026 for Quest Diagnostics, up from -$47.0 million in the prior quarter.
  • Over the last five years, Change in Receivables for DGX hit a ceiling of $180.0 million in Q1 2026 and a floor of -$84.0 million in Q4 2022.
  • Historically, Change in Receivables has averaged $7.4 million across 5 years, with a median of -$1.0 million in 2024.
  • Biggest five-year swings in Change in Receivables: plummeted 133.33% in 2022 and later soared 1500.0% in 2025.
  • Tracing DGX's Change in Receivables over 5 years: stood at -$84.0 million in 2022, then increased by 15.48% to -$71.0 million in 2023, then rose by 2.82% to -$69.0 million in 2024, then soared by 31.88% to -$47.0 million in 2025, then surged by 482.98% to $180.0 million in 2026.
  • Business Quant data shows Change in Receivables for DGX at $180.0 million in Q1 2026, -$47.0 million in Q4 2025, and $38.0 million in Q3 2025.